Over-the-counter use of short-acting beta-2 agonists: a systematic review.

J Pharm Policy Pract · 2023 · PMC10561505 · PMID 37814312

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In Australia, over-the-counter SABA overuse showed a decreasing trend between the year 2005 to 2017, with 39.6% and 24.3% of study participants reporting over-the-counter SABA use, respectively [ 40 , 45 ].

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.